DSE:SILCOPHL

Silco Pharmaceuticals Limited announcements

108 Dhaka Stock Exchange announcements for Silco Pharmaceuticals Limited (SILCOPHL) since 2020: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2021 (15).

  1. Resumption after record date

    Trading of the shares of the Company will resume on 21.12.2021 after record date.

  2. Suspension for Record date

    Trading of the shares of the Company will remain suspended on record date i.e., 20.12.2021.

  3. Spot News

    Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 15.12.2021 to 19.12.2021. Trading of the shares of the Company will remain suspended on record date i.e., 20.12.2021.

  4. Q1 Financials

    (Q1 Un-audited): EPS was Tk. 0.34 for July-September 2021 as against Tk. 0.33 for July-September 2020; NOCFPS was Tk. 0.38 for July-September 2021 as against Tk. 0.52 for July-September 2020. NAV per share was Tk. 22.18 as on September 30, 2021 and Tk. 21.85 as on June 30, 2021.

  5. The auditor of the Silco Pharmaceuticals Limited has given the \" Emphasis of Matter \" paragraph in the Auditor\'s Repo

    The auditor of the Silco Pharmaceuticals Limited has given the \" Emphasis of Matter \" paragraph in the Auditor\'s Report for the year ended on 30 June, 2021. Emphasis of Matter: We refer to note no: 2.15(b) & 18 relevant to the implementation of sec 234 of Bangladesh Labour Act-2006 regarding Workers Profit Participation Fund (WPPF). The company discloses its status for WPPF provisioning, subsequent payment & contribution to \'Bangladesh Labour welfare Foundation\' through (cont.1)

  6. Emphasis of Matter

    (Continuation news of SILCOPHL): designated government bank account as per requirement of Bangladesh Labour Act-2006. The Company's WPPF bank account held at Mercantile Bank Limited (Subidbazar Branch Acc No: 117912124312825). Our opinion is not modified in respect of this matter (end)

    The first part of this announcement is missing from the archive.
  7. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on December 06, 2021 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.

  8. The Board of Directors has recommended 10\% cash dividend for all shareholders excluding Directors for the year ended on

    The Board of Directors has recommended 10\% cash dividend for all shareholders excluding Directors for the year ended on June 30, 2021. The Directors hold 4,02,78,370 shares out of total 10,38,07,000 shares of the Company and the cash dividend to be payable to the General shareholders, Independent Directors and Sponsors only is Tk. 6,35,28,630.00. (cont.)

  9. Dividend Declaration

    (Continuation news of SILCOPHL): Date of AGM: 16.01.2022, Time: 11:30 AM, Venue: Digital Platform. Record Date: 20.12.2021. The Company has reported EPS of Tk. 0.82, NAV per share of Tk. 21.85 and NOCFPS of Tk. 2.48 the year ended on June 30, 2021 as against Tk. 0.80, Tk. 21.64 and Tk. 1.41 respectively for the same period of the previous year. (end)

    The first part of this announcement is missing from the archive.
  10. Price Limit Open

    There will be no price limit on the trading of the shares of the Company today (24.11.2021) following its corporate declaration.

  11. Board Meeting schedule under LR 19(1)

    As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 23, 2021 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.

  12. Q3 Financials

    (Q3 Un-audited): EPS was Tk. 0.32 for January-March 2021 as against Tk. 0.30 for January-March 2020; EPS was Tk. 0.77 for July 2020-March 2021 as against Tk. 0.81 for July 2019-March 2020. NOCFPS was Tk. 1.79 for July 2020-March 2021 as against Tk. 1.21 for July 2019-March 2020. NAV per share was Tk. 21.80 as on March 31, 2021 and Tk. 21.64 as on June 30, 2020.

  13. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 08, 2021 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.

  14. Q2 Financials

    (Q2 Un-audited): EPS was Tk. 0.12 for October-December 2020 as against Tk. 0.23 for October-December 2019; EPS was Tk. 0.45 for July-December 2020 as against Tk. 0.51 for July-December 2019. NOCFPS was Tk. 1.38 for July-December 2020 as against Tk. 1.00 for July-December 2019. NAV per share was Tk. 21.48 as on December 31, 2020 and Tk. 21.64 as on June 30, 2020.

  15. Dividend Disbursement

    The Company has informed that it has disbursed the cash dividend for General Shareholders excluding Sponsors & Directors for the year ended on June 30, 2020 to the respective shareholders' Bank Accounts through BEFTN system.

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.